Positron emission tomography in neuropsychiatric lupus erythematosus

We performed positron emission tomography (PET) using 18F-labeled 2-F-2-deoxyglucose in 13 patients with systemic lupus erythematosus (SLE). Ten of them had clinical signs of central nervous system involvement (NP-SLE). All patients with neurologic symptoms showed pathologic changes on PET, always in accordance with the clinical state. Three patients without neuropsychiatric manifestations had normal PETs. Computed tomography of the brain and magnetic resonance imaging proved to be less sensitive to both presence and localization of CNS lesions. We conclude that the combination of PET and MRI constitutes the most useful diagnostic procedure for NP-SLE.

[1]  A. Aisen,et al.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. , 1988, Arthritis and rheumatism.

[2]  H. Mamo,et al.  Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[3]  M. Reivich,et al.  Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications , 1987, Neurology.

[4]  D J Brooks,et al.  Measurement of Glucose Utilisation with [18F]2-Fluoro-2-Deoxy-D-Glucose: A Comparison of Different Analytical Methods , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  J. Denburg,et al.  Neuronal antibodies and cognitive function in systemic lupus erythematosus , 1987, Neurology.

[6]  J. Barrio,et al.  The synthesis of 2-[F-18]fluoro-2-deoxy-D-glucose using glycals: a reexamination. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  B. Bresnihan,et al.  The frequent occurrence of neurological disease in patients with late-onset systemic lupus erythematosus. , 1984, British journal of rheumatology.

[8]  G. Hughes,et al.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. , 1983, British medical journal.

[9]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[10]  H. Hashimoto,et al.  Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. , 1980, The Journal of clinical investigation.

[11]  P. Rooney,et al.  Cerebral systemic lupus erythematosus: a case report and evaluation of diagnostic tests. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[12]  M. Reivich,et al.  Effect of intracerebral vasculitis on regional cerebral blood flow. , 1979, Archives of neurology.

[13]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[14]  N. Funata.  Cerebral vascular changes in systemic lupus erythematosus. , 1979, The Bulletin of Tokyo Medical and Dental University.

[15]  R. Lahita,et al.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[16]  B. Bresnihan,et al.  An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[17]  R. Zimmerman,et al.  Cranial computed tomography in the diagnosis of systemic lupus erythematosus , 1979, Annals of neurology.

[18]  M. Verity,et al.  Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. , 1979, Seminars in arthritis and rheumatism.

[19]  H. Bluestein.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Travers,et al.  OXYGEN-15 BRAIN SCANNING FOR DETECTION OF CEREBRAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1978, The Lancet.

[21]  J Winter,et al.  Steroids and Apparent Cerebral Atrophy on Computed Tomography Scans , 1978, Journal of computer assisted tomography.

[22]  B. Bresnihan,et al.  Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. , 1977, Clinical and experimental immunology.

[23]  R. Zimmerman,et al.  Computed tomography of systemic lupus erythematosus. , 1977, Radiology.

[24]  R. Harbeck,et al.  Central nervous system involvement in sle , 1977 .

[25]  T. Gibson,et al.  Nervous system involvement in systemic lupus erythematosus , 1976, Annals of the rheumatic diseases.

[26]  F. Arnett,et al.  NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS, CLINICAL SPECTRUM, AND RELATIONSHIP TO OTHER FEATURES OF THE DISEASE , 1976, Medicine.

[27]  N. Zvaifler,et al.  Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. , 1976, The Journal of clinical investigation.

[28]  J. D. Shoop,et al.  Brain scan findings in central nervous system involvement by lupus erythematosus. , 1974, Annals of internal medicine.

[29]  N. Hadler,et al.  The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus. , 1973, Arthritis and rheumatism.

[30]  D. Estes,et al.  THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS , 1971, Medicine.

[31]  E. Richardson,et al.  The neurological manifestations of systemic lupus erythematosus. , 1968, Medicine.

[32]  R. Harbeck,et al.  Central nervous system involvement in SLE. Diagnostic profile and clinical features. , 1977, Arthritis and rheumatism.